Emergence of macrolide-resistant Streptococcus pyogenes strains in French children

被引:79
作者
Bingen, E
Bidet, P
Mihaila-Amrouche, L
Doit, C
Forcet, S
Brahimi, N
Bouvet, A
Cohen, R
机构
[1] Univ Paris 07, Microbiol Serv, Hop Robert Debre, Lab Etud Genet Bacterienne Infect Enfant, F-75019 Paris, France
[2] Univ Paris 05, Ctr Natl Reference Streptocoques, Microbiol Serv, Hotel Dieu, Paris, France
[3] Ctr Hosp, Microbiol Serv, Creteil, France
关键词
D O I
10.1128/AAC.48.9.3559-3562.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We studied the antimicrobial susceptibility of 322 Streptococcus pyogenes throat isolates from French children and their serotype and genomic diversity. A total of 22.4% were erythromycin resistant, and 69.4, 4.2, and 26.4% of these isolates harbored ermB, ermA, and mefA, respectively. Increasing resistance in France is mainly associated with a few emm type 28 clones.
引用
收藏
页码:3559 / 3562
页数:4
相关论文
共 21 条
[1]  
[Anonymous], M7A5 NCCLS
[2]   Erythromycin resistance in Streptococcus pyogenes in Italy [J].
Bassetti, M ;
Manno, G ;
Collidà, A ;
Ferrando, A ;
Gatti, G ;
Ugolotti, U ;
Cruciani, M ;
Bassetti, D .
EMERGING INFECTIOUS DISEASES, 2000, 6 (02) :180-183
[3]   Sequencing emm-specific PCR products for routine and accurate typing of group a streptococci [J].
Beall, B ;
Facklam, R ;
Thompson, T .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :953-958
[4]   Emergence of group a streptococcus strains with different mechanisms of macrolide resistance [J].
Bingen, E ;
Leclercq, R ;
Fitoussi, F ;
Brahimi, N ;
Malbruny, B ;
Deforche, D ;
Cohen, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1199-1203
[5]   Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients [J].
Bingen, E ;
Fitoussi, F ;
Doit, C ;
Cohen, R ;
Tanna, A ;
George, R ;
Loukil, C ;
Brahimi, N ;
Le Thomas, I ;
Deforche, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1453-1457
[6]   RESTRICTED ASSOCIATION BETWEEN BIOTYPES AND SEROTYPES WITHIN GROUP-A STREPTOCOCCI [J].
BOUVET, A ;
GESLIN, P ;
KRIZKUZEMENSKA, P ;
BLANC, V ;
DEVINE, C ;
GRIMONT, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (05) :1312-1317
[7]   Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe [J].
Bozdogan, B ;
Appelbaum, PC ;
Kelly, LM ;
Hoellman, DB ;
Tambic-Andrasevic, A ;
Drukalska, L ;
Hryniewicz, W ;
Hupkova, H ;
Jacobs, MR ;
Kolman, J ;
Konkoly-Thege, M ;
Miciuleviciene, J ;
Pana, M ;
Setchanova, L ;
Trupl, J ;
Urbaskova, P .
CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (07) :741-745
[8]   Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000 [J].
Cantón, R ;
Loza, E ;
Morosini, MI ;
Baquero, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 :9-24
[9]   Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada [J].
De Azavedo, JCS ;
Yeung, RH ;
Bast, DJ ;
Duncan, CL ;
Borgia, SB ;
Low, DE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2144-2147
[10]  
JOHNSON DR, 1996, LAB DIAGNOSIS GROUP, P37